TTE Improves Clinical Management of Stable Chest Pain
Recruiting
Observational Study
Transthorcic Echocardiography
Stable Angina Pectoris
Coronary Artery Disease
Major Adverse Cardiac Events
Invasive Coronary Angiography
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50,000 (estimated)
- Sponsor
- Tianjin Chest Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigator aims to prospectively enroll patients who were referred for transthorcic echocardiography (TTE) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent TTE according to established guidelines and local institutional protocols. This study will determine if TTE-based imaging evaluation can provide more informaton t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* symptomatic patients with SCP suspected of obstructive CAD.
* referred for TTE for the assessment of SCP.
* ≥18 years of age.
* signed informed consent.
Exclusion Criteria:
* acute coronary syndromes
* previous CAD or coronary revascularization
* nonsinus rhythm
* cardiomyop…
Contacts